Leveraging Patient Community & Machine Learning for Early Identification of Patients in Clinical Trials

Dive into our latest case studies to understand how Aptar Digital Health supports pharmaceutical companies in addressing some key challenges when undergoing clinical trials. Learn how leveraging patient communities and machine learning can derisk your clinical trial by accelerating recruitment, and enhancing study adherence.

In this comprehensive report, you’ll learn how Aptar Digital Health ‘s study platform is being used for several case such as:

• A virtual clinical trial for Phase II studies in migraine: Discover how a global leader company in nutrition and pharmaceuticals achieved fast recruitment, improved engagement, and timely insights with a fully virtual setup.
• A Real-World Evidence Study (RWE): Explore how a top 20 pharmaceutical company completed recruitment six months ahead of schedule and maintained compliance rates.